Stephanie Cohen, MS, CGC, LGC, is a board-certified and licensed genetic counselor in the Cancer Genetics Risk Assessment Program at Ascension St. Vincent in Indianapolis, Indiana. She earned her MS degree in Genetic Counseling at the University of Michigan. Ms. Cohen developed a stand-alone cancer genetics program that now includes three full-time genetic counselors and a genetic counseling assistant. She has been working to improve access to cancer genetic services by implementing a collaborative process, utilizing a network of genetic counselor extenders throughout the Ascension St. Vincent Health system across the state of Indiana.
She is active in training genetic counseling students by serving as a clinical supervisor and research advisor. She is chair of the Research, Quality and Outcomes Committee of the National Society of Genetic Counselors and is a Section Editor for the Journal of Genetic Counseling. She has multiple publications in the field of cancer genetics and genetic counseling service delivery.
Christopher S. Lathan, MD, MS, MPH, is the Chief Clinical Access and Equity Officer at Dana-Farber Cancer Institute, the Medical Director of Dana-Farber at St. Elizabeth’s Medical Center, Associate Medical Director of the Dana-Farber Cancer Institute Network and an Assistant Professor of Medicine at Harvard Medical School.
Dr. Lathan attended medical school at Tufts University School of Medicine and completed his postdoctoral training in internal medicine, medical oncology and cancer outcomes research at Boston Medical Center and the Dana-Farber/Harvard Cancer Center. Dr. Lathan also holds a master’s degree in public health from the Harvard School of Public Health, and a Master’s of Science degree in Cellular and Molecular Biology from the University of Massachusetts.
Dr. Lathan’s primary research interests are centered on the effects of race, class, and access to care on cancer outcomes, including racial disparities in lung cancer treatment, differences in somatic mutations across racial groups, perceptions of genetic testing by race and social class, population differences in targetable mutations in non-small cell lung cancer, and factors influencing willingness to participate in bio-banking among black men with and at-risk for prostate cancer. He is a board member of the National African American Cancer Coalition and the Medical and Scientific Advisory Board for the Lung Cancer Alliance. He is a past board member of the Conquer Cancer Coalition, and Boston Healthcare for the Homeless. Dr. Lathan also serves on the Health Disparities, Cancer Education and Scientific Review committees for the American Society of Clinical Oncology (ASCO) and the Minorities in Cancer Research Council for the American Association for Cancer Research (AACR).
Dr. Lathan aims to bridge the gap between research efforts in disparities and the realities of patient care by developing interventions to increase access to high level quality care, developed in part through a high level of community engagement. He is the founding Faculty Director of the Cancer Care Equity Program at the Dana-Farber Cancer Institute, and Director of Dana-Farber Community Cancer Care at Whittier Street Health Center in Roxbury, Massachusetts, a clinical outreach program that aids in the diagnosis and treatment of cancer for patients at a Federally Qualified Health Center, and integrates all three arms of clinical cancer care: prevention, diagnosis/treatment, and survivorship. This effort also provides an opportunity to improve clinical trial accrual among vulnerable populations.
Leeann is a bilingual Spanish oncology social worker and the coordinator of the Disparities Program at CancerCare, the leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.
Leeann provides supportive counseling and resources to patients, caregivers, and people who have experienced the loss of a loved one. She coordinates activities and outreach to address and discuss the healthcare disparities that patients and their families may face in oncology care.
Amy Jo Pixley, MSN, RN, OCN, ONN-CG(T), has been a nurse for over 30 years and currently is an oncology nurse navigator in thoracic and melanoma at the Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health in Lancaster, Pennsylvania. She has experience in pediatrics, adult and pediatric critical care and trauma, nursing administration, case management, and pediatric and adult oncology. She has served as adjunct faculty to the Lancaster General College and Health Sciences.
Ms. Pixley speaks nationally on topics in thoracic oncology and other cancer-related topics for community and support groups such as awareness lectures and intimacy after treatment. She has presented educational sessions on establishing Nurse Navigation programs to organizations such as the Pennsylvania Cancer Control Consortium. She has published articles for patients and caregivers in Conquer Magazine related to immunotherapy and shared decision making, and co-authored articles for the Journal of Oncology Navigation and Survivorship.
She is currently a certified oncology nurse, certified nurse navigator generalist and thoracic specialty, and a member of both the Oncology Nursing Society and the Academy of Oncology Nurse and Patient Navigators. Ms. Pixley received her undergraduate degree from Bloomsburg University and a Master of Science in Nursing from Walden University.
Funding & support provided by Janssen and Pfizer.